company overview description of the company and business segments becton, dickinson and company ("bd") is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. the company's organizational structure is based upon two principal business segments, bd medical ("medical") and bd life sciences ("life sciences").
â€¢   life sciences segment volume growth in 2017 was driven by growth in all three of its organizational units, particularly in its preanalytical and diagnostic systems units.
we continue to invest in research and development, geographic expansion, and new product promotions to drive further revenue and profit growth. our ability to sustain our long-term growth will depend on a number of factors, including our ability to expand our core business (including geographical expansion), develop innovative new products, and continue to improve operating efficiency and organizational effectiveness. while the economic environment for the healthcare industry and healthcare utilization in the united states have generally stabilized, destabilization in the future could adversely impact our businesses. additionally, macroeconomic challenges in europe continue to constrain healthcare utilization, although we currently view the environment as stable. in emerging markets, the company's growth is dependent primarily on government funding for healthcare systems. in addition, pricing pressure exists for certain geographies and could adversely impact our businesses.
results of operations medical segment the following is a summary of medical revenues by organizational unit:
life sciences segment the following is a summary of life sciences revenues by organizational unit: